| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |